PLAU and COVID-19: uPAR is implicated in uPA internalization and lysosomal degradation [38]; thereby, the lack of uPAR in the lung tissue of COVID-19 patients (Figure 1 and Figure 3) can contribute to excessive uPA accumulation (Figure 4), aggravating pulmonary fibrosis.